現任：
    ❖ 振興醫院大腸直腸外科 兼任主治醫師
    ❖ 臺北榮民總醫院大腸直腸外科外科主治醫師

學歷：
    ❖ 陽明大學臨床醫學研究所博士
    ❖ 哈佛大學流行病研究所碩士
    ❖ 高雄醫學院醫學系學士

經歷：
    ❖ 國立陽明大學醫學院副院長
    ❖ 國立陽明大學 醫學院 院長
    ❖ 國家衛生研究院癌症研究所研究員
    ❖ 臺北榮民總醫院實驗外科主任
    ❖ 哈佛大學醫學院訪問教授
    ❖ 國立陽明大學醫學院外科學科教授
    ❖ 日本國立癌病中心訪問研究員

專長：
    ❖ 大腸直腸癌手術治療
    ❖ 大腸直腸癌分子生物學研究
    ❖ 無痛性大腸鏡檢查
    ❖ 腸道腹腔鏡手術
    ❖ 癌症流病學
    ❖ 偏遠地區醫療服務
    ❖ 醫學教育

證照：
    ❖ 台灣外科醫學會 外科專科醫師
    ❖ 中華民國大腸直腸外科醫學會專科醫師

論文發表：(節錄)
    1. Lin H.H., Lin J.K., Lin C.C., Lan Y.T., Wang H.S., Yang S.H., Jiang J.K., Chen W.S., Lin T.C., Liang W.Y., Chang S.C.. Circumferential margin plays an independent impact on the outcome of rectal cancer patients receiving curative total mesorectal excision. Am J Surg. 2013 Nov;206(5):771-7.
    2. Tsai C.H., Yang C.W., Wang J.Y., Tsai Y.F., Tseng L.M., King K.L., Chen W.S., Chiu J.H., ShyrY.M.. Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells. Evid Based Complement AlternatMed. Epub 2013 Jun 25.
    3. Wang J.Y., Lee C.Y., Pan P.J., Chang W.C., Chiu J.H., Chen W.S., Shyr Y.M.. Herb-induced autoimmune-like hepatitis in C57BL/6J mice. Liver Int. 2013 Jul 1.
    4. Shao Y.C., Chang Y.Y., Lin J.K., Lin C.C., Wang H.S., Yang S.H., Jiang J.K., Lan Y.T., Lin T.C., Li A.F., Chen W.S., Chang S.C.. Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis. Int J Colorectal Dis. 2013 May 22.
    5. Lai C.C., Chen W.S., Chang Y.S., Wang S.H., Huang C.J., Guo W.Y., Yang W.C., Huang D.F..Clinical Features and Outcomes of Posterior Reversible Encephalopathy Syndrome in Patients with Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2013 May 17.
    6. Cheng A.N., Jiang S.S., Fan C.C., Lo Y.K., Kuo C.Y., Chen C.H., Liu Y.L., Lee C.C., Chen W.S., Huang T.S., Wang T.Y., Lee A.Y.. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.Cancer Lett. 2013 May 16.
    7. Lu Y.J., Lin P.C., Lin C.C., Wang H.S., Yang S.H., Jiang J.K., Lan Y.T., Lin T.C., Liang W.Y.,Chen W.S., Lin J.K., Chang S.C.. The Impact of the Lymph Node Ratio is Greater than Traditional Lymph Node Status in Stage III Colorectal Cancer Patients. World J Surg. 2013 Apr 23.
    8. Yang K.L., Yang S.H., Liang W.Y., Kuo Y.J., Lin J.K., Lin T.C., Chen W.S., Jiang J.K., Wang H.S., Chang S.C., Chu L.S., Wang L.W.. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.Radiat Oncol. 2013 Mar; 8(1):43.
    9. Lin P.C., Lin H.H., Lin J.K., Lin C.C., Yang S.H., Li A.F., Chen W.S., Chang S.C.. Expression of ABCG2 associated with tumor response in 
metastatic colorectal cancer patients receiving first-line
FOLFOX therapy – preliminary evidence. Int J Biol Markers. 2013; 28(2): 182 – 186.
    10. Yang K.L., Yang S.H., Liang W.Y., Kuo Y.J., Lin J.K., Lin T.C., Chen W.S., Jiang J.K., Wang H.S., Chang S.C., Chu L.S., Wang L.W.. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.Radiat Oncol. 2013 Mar 1;8:43.